Dr Mark Graham was appointed to the Committee in September 2010. He is a Senior Principal Scientist in the Department of Safety Assessment at AstraZeneca R & D, Alderley Park, Cheshire. Mark has over 25 years experience in Pharmaceutical Toxicology with a special interest in the use of Toxicology to aid Drug Discovery and design. He has a wide range of research interests including toxicological aspects of enzyme induction and the role of the novel protein cytoglobin in toxicological responses. Mark has supervised many PhD students in collaboration with colleagues in several Universities and in 2006 he was made a visiting Professor at the University of Surrey. Mark is a Fellow of the British Toxicology Society and a member of the Editorial Board of the journal Xenobiotica.
Dr Graham’s appointment as a member of the Committee expires on 31 March 2019.